| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 213 | 2024 | 12076 | 8.620 |
Why?
|
| Metformin | 37 | 2023 | 906 | 4.550 |
Why?
|
| Hypoglycemic Agents | 35 | 2023 | 3068 | 3.430 |
Why?
|
| Polymorphism, Single Nucleotide | 143 | 2024 | 15773 | 3.400 |
Why?
|
| Blood Glucose | 73 | 2023 | 6349 | 2.920 |
Why?
|
| Genome-Wide Association Study | 113 | 2024 | 12604 | 2.780 |
Why?
|
| Genetic Predisposition to Disease | 102 | 2024 | 17767 | 2.430 |
Why?
|
| Pharmacogenetics | 11 | 2020 | 675 | 2.280 |
Why?
|
| Glipizide | 6 | 2023 | 48 | 2.160 |
Why?
|
| Insulin | 56 | 2023 | 6578 | 1.960 |
Why?
|
| Insulin Resistance | 42 | 2024 | 3941 | 1.910 |
Why?
|
| Genetic Variation | 46 | 2024 | 6549 | 1.910 |
Why?
|
| Fasting | 27 | 2022 | 1599 | 1.690 |
Why?
|
| Diabetic Nephropathies | 13 | 2024 | 973 | 1.610 |
Why?
|
| Diabetes Mellitus | 26 | 2024 | 5815 | 1.530 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 11 | 2018 | 152 | 1.450 |
Why?
|
| Sulfonylurea Compounds | 5 | 2021 | 219 | 1.370 |
Why?
|
| Genotype | 66 | 2023 | 12951 | 1.360 |
Why?
|
| Hyperglycemia | 8 | 2023 | 1367 | 1.260 |
Why?
|
| Proinsulin | 6 | 2023 | 135 | 1.240 |
Why?
|
| Incretins | 4 | 2022 | 98 | 1.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 17 | 2024 | 3432 | 1.120 |
Why?
|
| TCF Transcription Factors | 7 | 2010 | 138 | 1.100 |
Why?
|
| Genetic Loci | 21 | 2022 | 2612 | 1.100 |
Why?
|
| Obesity | 35 | 2023 | 12869 | 0.970 |
Why?
|
| Glucose | 21 | 2023 | 4336 | 0.940 |
Why?
|
| Polymorphism, Genetic | 10 | 2012 | 4283 | 0.940 |
Why?
|
| Mendelian Randomization Analysis | 12 | 2022 | 993 | 0.910 |
Why?
|
| Prediabetic State | 9 | 2024 | 547 | 0.850 |
Why?
|
| Amino Acid Substitution | 9 | 2018 | 1734 | 0.820 |
Why?
|
| Humans | 322 | 2024 | 757650 | 0.810 |
Why?
|
| Alleles | 37 | 2022 | 6894 | 0.770 |
Why?
|
| Gene Frequency | 31 | 2024 | 3612 | 0.760 |
Why?
|
| Haplotypes | 12 | 2021 | 2764 | 0.760 |
Why?
|
| Diabetes, Gestational | 9 | 2024 | 1241 | 0.740 |
Why?
|
| Diabetes Complications | 2 | 2020 | 1317 | 0.710 |
Why?
|
| Multifactorial Inheritance | 12 | 2024 | 1365 | 0.700 |
Why?
|
| Anti-Obesity Agents | 1 | 2023 | 227 | 0.700 |
Why?
|
| Glucose Tolerance Test | 17 | 2023 | 1173 | 0.690 |
Why?
|
| Pyrophosphatases | 6 | 2010 | 139 | 0.670 |
Why?
|
| Phenotype | 35 | 2024 | 16533 | 0.670 |
Why?
|
| Receptor, Melatonin, MT2 | 5 | 2022 | 81 | 0.670 |
Why?
|
| Glucokinase | 3 | 2021 | 102 | 0.670 |
Why?
|
| Phosphoric Diester Hydrolases | 6 | 2010 | 198 | 0.650 |
Why?
|
| Quantitative Trait Loci | 21 | 2022 | 2100 | 0.650 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 782 | 0.640 |
Why?
|
| Body Mass Index | 41 | 2024 | 12870 | 0.640 |
Why?
|
| Genome, Human | 13 | 2021 | 4414 | 0.630 |
Why?
|
| Genetic Linkage | 7 | 2016 | 2381 | 0.620 |
Why?
|
| Life Style | 23 | 2022 | 3886 | 0.610 |
Why?
|
| Linkage Disequilibrium | 13 | 2021 | 1996 | 0.610 |
Why?
|
| Genomics | 11 | 2023 | 5788 | 0.600 |
Why?
|
| Metabolome | 8 | 2022 | 982 | 0.580 |
Why?
|
| Glucose Intolerance | 4 | 2023 | 575 | 0.580 |
Why?
|
| Insulin-Secreting Cells | 8 | 2024 | 896 | 0.570 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2009 | 144 | 0.560 |
Why?
|
| PPAR gamma | 6 | 2016 | 482 | 0.560 |
Why?
|
| Weight Loss | 12 | 2023 | 2671 | 0.540 |
Why?
|
| Risk Reduction Behavior | 5 | 2017 | 1098 | 0.540 |
Why?
|
| Hypoglycemia | 2 | 2023 | 881 | 0.530 |
Why?
|
| Risk Factors | 63 | 2024 | 73716 | 0.520 |
Why?
|
| Female | 166 | 2024 | 389985 | 0.510 |
Why?
|
| Receptors, Drug | 2 | 2007 | 157 | 0.510 |
Why?
|
| Chemokines, CC | 1 | 2016 | 283 | 0.500 |
Why?
|
| Multigene Family | 1 | 2018 | 1076 | 0.500 |
Why?
|
| Male | 152 | 2024 | 358227 | 0.490 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2021 | 553 | 0.480 |
Why?
|
| Amino Acids, Aromatic | 2 | 2013 | 36 | 0.470 |
Why?
|
| Receptors, Glucagon | 2 | 2015 | 90 | 0.470 |
Why?
|
| Chromans | 4 | 2011 | 117 | 0.460 |
Why?
|
| Monocarboxylic Acid Transporters | 4 | 2019 | 80 | 0.460 |
Why?
|
| Metabolic Diseases | 2 | 2018 | 682 | 0.460 |
Why?
|
| Albuminuria | 2 | 2015 | 650 | 0.450 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 4 | 2017 | 92 | 0.450 |
Why?
|
| Kidney Failure, Chronic | 7 | 2021 | 2455 | 0.450 |
Why?
|
| Chymotrypsin | 1 | 2013 | 138 | 0.450 |
Why?
|
| Diet | 9 | 2023 | 8003 | 0.430 |
Why?
|
| Middle Aged | 107 | 2024 | 219219 | 0.430 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 4624 | 0.430 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2021 | 540 | 0.420 |
Why?
|
| Adult | 100 | 2024 | 219747 | 0.420 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 890 | 0.420 |
Why?
|
| Potassium Channels | 2 | 2007 | 534 | 0.420 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.410 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2007 | 563 | 0.400 |
Why?
|
| Tryptophan Hydroxylase | 3 | 1996 | 94 | 0.400 |
Why?
|
| Islets of Langerhans | 7 | 2024 | 1345 | 0.400 |
Why?
|
| Dietary Fats | 2 | 2019 | 1991 | 0.390 |
Why?
|
| Down Syndrome | 4 | 2017 | 892 | 0.390 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2013 | 263 | 0.380 |
Why?
|
| Carcinoid Tumor | 1 | 2013 | 224 | 0.380 |
Why?
|
| Pineal Gland | 3 | 1996 | 157 | 0.380 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2013 | 617 | 0.380 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2013 | 52 | 0.380 |
Why?
|
| Thiazolidinediones | 4 | 2011 | 461 | 0.370 |
Why?
|
| Genetic Association Studies | 13 | 2020 | 2717 | 0.370 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2013 | 178 | 0.360 |
Why?
|
| Case-Control Studies | 33 | 2024 | 22024 | 0.360 |
Why?
|
| Mutation, Missense | 9 | 2019 | 2565 | 0.350 |
Why?
|
| Cardiovascular Diseases | 14 | 2024 | 15394 | 0.350 |
Why?
|
| Knowledge | 2 | 2010 | 176 | 0.340 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 270 | 0.340 |
Why?
|
| Cerebrospinal Fluid | 1 | 2012 | 544 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1404 | 0.340 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 5 | 2018 | 169 | 0.330 |
Why?
|
| Genetic Markers | 7 | 2023 | 2608 | 0.330 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 311 | 0.330 |
Why?
|
| Coronary Artery Disease | 6 | 2024 | 6363 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2008 | 347 | 0.310 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 3443 | 0.300 |
Why?
|
| Resistin | 1 | 2008 | 172 | 0.300 |
Why?
|
| Information Dissemination | 1 | 2016 | 1128 | 0.300 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2082 | 0.290 |
Why?
|
| Primary Prevention | 1 | 2015 | 1185 | 0.290 |
Why?
|
| Incidence | 21 | 2024 | 21217 | 0.280 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2021 | 128 | 0.280 |
Why?
|
| Phosphoproteins | 2 | 2007 | 2433 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1740 | 0.280 |
Why?
|
| Cohort Studies | 27 | 2024 | 41198 | 0.280 |
Why?
|
| Genetic Counseling | 4 | 2016 | 624 | 0.280 |
Why?
|
| Cation Transport Proteins | 4 | 2014 | 324 | 0.270 |
Why?
|
| Homeostasis | 7 | 2019 | 3302 | 0.270 |
Why?
|
| Insulysin | 1 | 2006 | 49 | 0.260 |
Why?
|
| Reproduction | 2 | 2012 | 646 | 0.260 |
Why?
|
| Lysine | 3 | 2008 | 998 | 0.260 |
Why?
|
| Adiponectin | 5 | 2012 | 1114 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2796 | 0.260 |
Why?
|
| DNA | 2 | 2022 | 7199 | 0.250 |
Why?
|
| Founder Effect | 2 | 2018 | 186 | 0.250 |
Why?
|
| Hydrocortisone | 1 | 2013 | 1802 | 0.250 |
Why?
|
| Waist-Hip Ratio | 7 | 2022 | 516 | 0.250 |
Why?
|
| C-Peptide | 3 | 2023 | 433 | 0.240 |
Why?
|
| Meta-Analysis as Topic | 11 | 2021 | 1373 | 0.240 |
Why?
|
| Aged | 56 | 2024 | 167889 | 0.240 |
Why?
|
| Placenta | 2 | 2024 | 1702 | 0.240 |
Why?
|
| Sphenoid Sinus | 1 | 2005 | 99 | 0.240 |
Why?
|
| Proportional Hazards Models | 9 | 2019 | 12400 | 0.240 |
Why?
|
| Risk | 12 | 2020 | 9590 | 0.240 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2005 | 101 | 0.230 |
Why?
|
| Exercise | 5 | 2021 | 5788 | 0.230 |
Why?
|
| Genetics, Population | 3 | 2021 | 929 | 0.230 |
Why?
|
| Lipids | 4 | 2021 | 3326 | 0.230 |
Why?
|
| Databases, Genetic | 5 | 2021 | 1737 | 0.230 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2024 | 126 | 0.230 |
Why?
|
| Triglycerides | 9 | 2022 | 2450 | 0.230 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2005 | 327 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.220 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 1267 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 459 | 0.210 |
Why?
|
| Circadian Rhythm | 5 | 2020 | 2567 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 2800 | 0.210 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 3754 | 0.210 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 665 | 0.200 |
Why?
|
| Hypercalcemia | 1 | 2005 | 422 | 0.200 |
Why?
|
| Rhabdomyosarcoma | 1 | 2005 | 358 | 0.200 |
Why?
|
| Waist Circumference | 5 | 2022 | 922 | 0.200 |
Why?
|
| Melatonin | 4 | 2022 | 668 | 0.190 |
Why?
|
| Energy Intake | 3 | 2018 | 2127 | 0.190 |
Why?
|
| Environment | 4 | 2016 | 1118 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2005 | 376 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2006 | 1686 | 0.190 |
Why?
|
| Dyslipidemias | 3 | 2021 | 867 | 0.190 |
Why?
|
| Mannosidases | 1 | 2020 | 21 | 0.190 |
Why?
|
| Proteins | 7 | 2019 | 6026 | 0.190 |
Why?
|
| Disease Progression | 8 | 2024 | 13464 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2013 | 313 | 0.180 |
Why?
|
| Vitamin D Deficiency | 3 | 2018 | 1377 | 0.180 |
Why?
|
| Mexico | 5 | 2018 | 758 | 0.180 |
Why?
|
| Membrane Proteins | 5 | 2018 | 7841 | 0.180 |
Why?
|
| Genes, Recessive | 2 | 2022 | 626 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 7799 | 0.180 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 1264 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1055 | 0.170 |
Why?
|
| Mexican Americans | 2 | 2017 | 165 | 0.170 |
Why?
|
| Cluster Analysis | 4 | 2022 | 2696 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2040 | 0.170 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 36 | 0.170 |
Why?
|
| Bone Density | 2 | 2012 | 3533 | 0.170 |
Why?
|
| Prospective Studies | 15 | 2024 | 54108 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 855 | 0.170 |
Why?
|
| Finland | 3 | 2017 | 603 | 0.170 |
Why?
|
| Genetic Heterogeneity | 4 | 2016 | 723 | 0.170 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2019 | 40 | 0.170 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2022 | 362 | 0.170 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11893 | 0.170 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8543 | 0.160 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 1634 | 0.160 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3826 | 0.160 |
Why?
|
| Collagen Type IV | 1 | 2019 | 127 | 0.160 |
Why?
|
| 2-Aminoadipic Acid | 2 | 2022 | 33 | 0.160 |
Why?
|
| Odds Ratio | 6 | 2019 | 9624 | 0.160 |
Why?
|
| Skin Diseases | 1 | 2007 | 1088 | 0.160 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 262 | 0.160 |
Why?
|
| Adiposity | 5 | 2022 | 1858 | 0.160 |
Why?
|
| Endocrinology | 2 | 2020 | 441 | 0.160 |
Why?
|
| Europe | 7 | 2022 | 3415 | 0.160 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2015 | 72 | 0.150 |
Why?
|
| Cytosine | 1 | 2019 | 210 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2021 | 814 | 0.150 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2018 | 42 | 0.150 |
Why?
|
| Hyperuricemia | 1 | 2021 | 224 | 0.150 |
Why?
|
| Biotransformation | 1 | 2018 | 166 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 502 | 0.150 |
Why?
|
| Algorithms | 5 | 2023 | 13952 | 0.150 |
Why?
|
| Decision Making | 2 | 2012 | 3909 | 0.150 |
Why?
|
| Massachusetts | 6 | 2013 | 8815 | 0.150 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 25931 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2013 | 2895 | 0.140 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3401 | 0.140 |
Why?
|
| Glycerol | 1 | 2018 | 275 | 0.140 |
Why?
|
| Bayes Theorem | 3 | 2022 | 2320 | 0.140 |
Why?
|
| Exercise Therapy | 4 | 2019 | 919 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2023 | 3782 | 0.140 |
Why?
|
| Overweight | 4 | 2016 | 2408 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2023 | 2636 | 0.140 |
Why?
|
| Body Height | 2 | 2017 | 1567 | 0.140 |
Why?
|
| Sodium | 1 | 2022 | 1588 | 0.140 |
Why?
|
| Longitudinal Studies | 8 | 2024 | 14478 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2016 | 61 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 9574 | 0.140 |
Why?
|
| Genomic Library | 1 | 1996 | 189 | 0.140 |
Why?
|
| Causality | 3 | 2021 | 1241 | 0.140 |
Why?
|
| Vitamin D | 3 | 2018 | 3283 | 0.140 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 1313 | 0.140 |
Why?
|
| Metabolomics | 2 | 2018 | 1629 | 0.130 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 405 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 211 | 0.130 |
Why?
|
| Adipocytes | 2 | 2024 | 1178 | 0.130 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 393 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 268 | 0.130 |
Why?
|
| Transcription Factors | 7 | 2023 | 12092 | 0.130 |
Why?
|
| Betaine | 1 | 2016 | 89 | 0.130 |
Why?
|
| Chromosomes, Human, X | 1 | 2018 | 321 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2006 | 2976 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2021 | 4710 | 0.130 |
Why?
|
| Glucagon | 1 | 2018 | 532 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 540 | 0.130 |
Why?
|
| Disease | 1 | 2021 | 671 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2014 | 410 | 0.130 |
Why?
|
| Diet, Reducing | 2 | 2016 | 485 | 0.130 |
Why?
|
| Mutation | 4 | 2022 | 29928 | 0.130 |
Why?
|
| Lipodystrophy | 1 | 2016 | 148 | 0.130 |
Why?
|
| Adolescent | 16 | 2024 | 87832 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 86 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2017 | 597 | 0.120 |
Why?
|
| Lipid Metabolism | 4 | 2021 | 1894 | 0.120 |
Why?
|
| Autoantigens | 1 | 2019 | 877 | 0.120 |
Why?
|
| Cryptochromes | 1 | 2015 | 48 | 0.120 |
Why?
|
| Pregnancy | 12 | 2024 | 29720 | 0.120 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 20039 | 0.120 |
Why?
|
| Aging | 3 | 2021 | 8650 | 0.120 |
Why?
|
| NAD | 1 | 2019 | 609 | 0.120 |
Why?
|
| United States | 21 | 2022 | 71907 | 0.120 |
Why?
|
| Glycolysis | 1 | 2019 | 826 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 86 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2019 | 567 | 0.120 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.120 |
Why?
|
| Consensus | 2 | 2023 | 3098 | 0.120 |
Why?
|
| Enteroendocrine Cells | 2 | 2024 | 77 | 0.120 |
Why?
|
| Homeodomain Proteins | 7 | 2023 | 2412 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2014 | 6336 | 0.120 |
Why?
|
| Area Under Curve | 2 | 2018 | 1632 | 0.110 |
Why?
|
| Evidence-Based Medicine | 4 | 2023 | 3667 | 0.110 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 251 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1788 | 0.110 |
Why?
|
| Fetus | 1 | 2021 | 1860 | 0.110 |
Why?
|
| Motor Activity | 3 | 2015 | 2686 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2013 | 17 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1135 | 0.110 |
Why?
|
| Gout | 1 | 2021 | 618 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2012 | 786 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 101 | 0.110 |
Why?
|
| Treatment Outcome | 9 | 2023 | 64242 | 0.110 |
Why?
|
| Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 2017 | 386 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.110 |
Why?
|
| Norepinephrine | 1 | 1996 | 897 | 0.110 |
Why?
|
| DNA Methylation | 3 | 2023 | 4374 | 0.110 |
Why?
|
| Risk Assessment | 10 | 2021 | 23819 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 39 | 0.110 |
Why?
|
| Heart Diseases | 2 | 2018 | 2780 | 0.110 |
Why?
|
| Siblings | 3 | 2006 | 824 | 0.110 |
Why?
|
| Mitochondria | 2 | 2019 | 3584 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3774 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 174 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 1475 | 0.110 |
Why?
|
| Plasma | 1 | 2016 | 584 | 0.110 |
Why?
|
| Animals | 21 | 2020 | 167777 | 0.110 |
Why?
|
| Nephrology | 1 | 2016 | 263 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 546 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2019 | 1271 | 0.100 |
Why?
|
| Receptors, Adiponectin | 1 | 2012 | 81 | 0.100 |
Why?
|
| Carbolines | 1 | 2014 | 286 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 263 | 0.100 |
Why?
|
| Eating | 4 | 2023 | 1537 | 0.100 |
Why?
|
| Behavior | 1 | 1995 | 540 | 0.100 |
Why?
|
| Health Behavior | 3 | 2016 | 2615 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1455 | 0.100 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2022 | 26 | 0.100 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2021 | 102 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2018 | 1593 | 0.100 |
Why?
|
| Nuclear Proteins | 4 | 2021 | 5786 | 0.100 |
Why?
|
| Predictive Value of Tests | 7 | 2023 | 15209 | 0.100 |
Why?
|
| Birth Weight | 2 | 2020 | 2096 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2017 | 665 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1170 | 0.100 |
Why?
|
| Heterozygote | 5 | 2018 | 2797 | 0.100 |
Why?
|
| Genetic Testing | 5 | 2012 | 3529 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 524 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1361 | 0.100 |
Why?
|
| RNA, Messenger | 5 | 2023 | 12761 | 0.100 |
Why?
|
| Sweden | 2 | 2021 | 1376 | 0.100 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 451 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2018 | 3441 | 0.090 |
Why?
|
| Liver | 6 | 2021 | 7503 | 0.090 |
Why?
|
| Seasons | 2 | 2015 | 1518 | 0.090 |
Why?
|
| Pedigree | 4 | 2017 | 4578 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 872 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 2825 | 0.090 |
Why?
|
| Population Groups | 1 | 2012 | 208 | 0.090 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Receptors, Peptide | 1 | 2012 | 279 | 0.090 |
Why?
|
| Cholesterol, LDL | 4 | 2022 | 2374 | 0.090 |
Why?
|
| Placebos | 2 | 2012 | 1661 | 0.090 |
Why?
|
| Weight Gain | 3 | 2023 | 2345 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 568 | 0.090 |
Why?
|
| Body Composition | 3 | 2019 | 2416 | 0.090 |
Why?
|
| Androgens | 2 | 2015 | 1284 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 137 | 0.090 |
Why?
|
| Natriuretic Peptides | 1 | 2011 | 155 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 1702 | 0.090 |
Why?
|
| Pancreas | 2 | 2014 | 1676 | 0.090 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 369 | 0.090 |
Why?
|
| Poland | 2 | 2007 | 196 | 0.090 |
Why?
|
| Computational Biology | 5 | 2023 | 3501 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 170 | 0.080 |
Why?
|
| Motivation | 4 | 2012 | 1996 | 0.080 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9404 | 0.080 |
Why?
|
| Endonucleases | 1 | 2012 | 369 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2237 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 977 | 0.080 |
Why?
|
| Adipose Tissue | 4 | 2017 | 3299 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1044 | 0.080 |
Why?
|
| Prevalence | 5 | 2023 | 15641 | 0.080 |
Why?
|
| Canada | 2 | 2022 | 2108 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Iceland | 1 | 2009 | 184 | 0.080 |
Why?
|
| Receptor, Insulin | 2 | 2013 | 833 | 0.080 |
Why?
|
| Sex Factors | 6 | 2022 | 10497 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 869 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 251 | 0.080 |
Why?
|
| Cholesterol, HDL | 4 | 2022 | 1808 | 0.080 |
Why?
|
| Body Weight | 4 | 2017 | 4602 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13267 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2023 | 4760 | 0.080 |
Why?
|
| Estrogens | 1 | 2015 | 1521 | 0.080 |
Why?
|
| Colombia | 1 | 2009 | 276 | 0.080 |
Why?
|
| Cell Movement | 1 | 2020 | 5201 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2016 | 822 | 0.080 |
Why?
|
| Young Adult | 13 | 2024 | 58764 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2443 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 791 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 162 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 1704 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2018 | 7926 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 385 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2020 | 3182 | 0.070 |
Why?
|
| RNA-Binding Proteins | 5 | 2016 | 1895 | 0.070 |
Why?
|
| Sample Size | 3 | 2016 | 838 | 0.070 |
Why?
|
| Physicians, Family | 1 | 2009 | 349 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 687 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 866 | 0.070 |
Why?
|
| Follow-Up Studies | 9 | 2022 | 39018 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1133 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 2 | 1996 | 113 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4113 | 0.070 |
Why?
|
| Epigenomics | 2 | 2024 | 936 | 0.070 |
Why?
|
| Logistic Models | 4 | 2016 | 13222 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2868 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 1991 | 1199 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2008 | 397 | 0.070 |
Why?
|
| Health Literacy | 1 | 2012 | 438 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 940 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 635 | 0.070 |
Why?
|
| Chest Pain | 1 | 2013 | 1090 | 0.070 |
Why?
|
| Mental Health | 1 | 2020 | 3231 | 0.070 |
Why?
|
| Fatigue | 1 | 2013 | 1544 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11075 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2870 | 0.060 |
Why?
|
| Age of Onset | 3 | 2023 | 3296 | 0.060 |
Why?
|
| Osteoporosis | 2 | 2012 | 1599 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 95 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 601 | 0.060 |
Why?
|
| Aged, 80 and over | 10 | 2024 | 58559 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1245 | 0.060 |
Why?
|
| Models, Biological | 2 | 2018 | 9460 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1177 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2019 | 18941 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 4406 | 0.060 |
Why?
|
| Coronary Disease | 2 | 2017 | 5913 | 0.060 |
Why?
|
| Chick Embryo | 2 | 1996 | 981 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2010 | 1518 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 8981 | 0.060 |
Why?
|
| Glutamine | 1 | 2006 | 575 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 8502 | 0.060 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.060 |
Why?
|
| Calcium | 1 | 1996 | 5722 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 933 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7366 | 0.050 |
Why?
|
| Mice | 10 | 2019 | 81107 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 8164 | 0.050 |
Why?
|
| Glutamic Acid | 2 | 2008 | 1167 | 0.050 |
Why?
|
| Child | 10 | 2024 | 79787 | 0.050 |
Why?
|
| tRNA Methyltransferases | 2 | 2016 | 52 | 0.050 |
Why?
|
| PubMed | 1 | 2023 | 128 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2018 | 1186 | 0.050 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2022 | 21 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 597 | 0.050 |
Why?
|
| Homozygote | 2 | 2022 | 1788 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2023 | 204 | 0.050 |
Why?
|
| Gene Expression | 4 | 2021 | 7584 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 6957 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1704 | 0.050 |
Why?
|
| Quality of Life | 2 | 2020 | 13265 | 0.050 |
Why?
|
| Biology | 1 | 2024 | 289 | 0.050 |
Why?
|
| Stroke | 2 | 2021 | 9695 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1135 | 0.050 |
Why?
|
| Subcutaneous Fat | 2 | 2019 | 393 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 5779 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5098 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 182 | 0.050 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2021 | 57 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2038 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 321 | 0.050 |
Why?
|
| Drosophila | 2 | 2019 | 1491 | 0.050 |
Why?
|
| Spain | 1 | 2022 | 488 | 0.040 |
Why?
|
| Comorbidity | 1 | 2015 | 10478 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2010 | 2413 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4937 | 0.040 |
Why?
|
| Mannose | 1 | 2020 | 121 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1828 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 1991 | 3705 | 0.040 |
Why?
|
| Spermine Synthase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Diphosphonates | 1 | 2005 | 636 | 0.040 |
Why?
|
| Receptors, Odorant | 1 | 2020 | 67 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 350 | 0.040 |
Why?
|
| Access to Information | 1 | 2023 | 316 | 0.040 |
Why?
|
| Introns | 2 | 2016 | 978 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 697 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 388 | 0.040 |
Why?
|
| Base Sequence | 2 | 2013 | 12437 | 0.040 |
Why?
|
| Hyperinsulinism | 2 | 2013 | 400 | 0.040 |
Why?
|
| Gout Suppressants | 1 | 2021 | 177 | 0.040 |
Why?
|
| Imidazoles | 1 | 2005 | 1179 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 10135 | 0.040 |
Why?
|
| Financial Management | 1 | 2020 | 160 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2019 | 144 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4690 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2019 | 263 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 2019 | 85 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 986 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2020 | 3887 | 0.040 |
Why?
|
| Boston | 3 | 2016 | 9297 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 1221 | 0.040 |
Why?
|
| Lipoprotein Lipase | 1 | 2018 | 133 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 340 | 0.040 |
Why?
|
| Taurine | 1 | 2018 | 93 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4107 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2020 | 361 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 224 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14354 | 0.040 |
Why?
|
| Body Fat Distribution | 1 | 2019 | 243 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8515 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2021 | 42044 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 1095 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2024 | 623 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 336 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2621 | 0.040 |
Why?
|
| Cell Size | 1 | 2019 | 624 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2023 | 1167 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| Somatomedins | 1 | 2017 | 178 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2018 | 365 | 0.030 |
Why?
|
| Genetic Code | 1 | 1996 | 138 | 0.030 |
Why?
|
| Isomerism | 1 | 1996 | 197 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 155 | 0.030 |
Why?
|
| Xanthines | 1 | 2016 | 120 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 2016 | 79 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 1996 | 69 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 52 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1996 | 283 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 604 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5857 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 289 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 362 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1996 | 366 | 0.030 |
Why?
|
| China | 1 | 2022 | 2336 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1411 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 232 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2048 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 866 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2017 | 2859 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 419 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 1991 | 0.030 |
Why?
|
| Infant | 4 | 2021 | 36043 | 0.030 |
Why?
|
| Autoradiography | 1 | 1996 | 730 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11422 | 0.030 |
Why?
|
| Health Surveys | 2 | 2016 | 4057 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6151 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 5031 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 260 | 0.030 |
Why?
|
| Cell Line | 3 | 2017 | 15594 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1788 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1824 | 0.030 |
Why?
|
| Interdisciplinary Studies | 1 | 2015 | 86 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2016 | 173 | 0.030 |
Why?
|
| Time Factors | 5 | 2022 | 39815 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1543 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 183 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 803 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13447 | 0.030 |
Why?
|
| Glycine | 1 | 2018 | 662 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22008 | 0.030 |
Why?
|
| Chickens | 1 | 1996 | 859 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15782 | 0.030 |
Why?
|
| Binding Sites | 2 | 2015 | 6036 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2625 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 584 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2019 | 1133 | 0.030 |
Why?
|
| Neoplasms | 3 | 2024 | 21990 | 0.030 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 28 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1743 | 0.030 |
Why?
|
| Methionine | 1 | 1996 | 569 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 605 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2011 | 1716 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 1233 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2023 | 2145 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17617 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 801 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1906 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 2013 | 73 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 582 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 79982 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 832 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 667 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 731 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1991 | 0.030 |
Why?
|
| Biological Clocks | 1 | 1995 | 316 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 658 | 0.030 |
Why?
|
| Family Health | 1 | 2017 | 1256 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2013 | 23342 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2379 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 933 | 0.030 |
Why?
|
| Parents | 1 | 2006 | 3548 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2023 | 6293 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 2904 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1694 | 0.030 |
Why?
|
| Transaminases | 1 | 2013 | 196 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1246 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 159 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2015 | 393 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 867 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2753 | 0.030 |
Why?
|
| Ireland | 1 | 2012 | 171 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1995 | 1751 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 768 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2938 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1995 | 317 | 0.020 |
Why?
|
| Lysophospholipase | 1 | 2011 | 65 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 419 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2018 | 1507 | 0.020 |
Why?
|
| Cricetinae | 1 | 1995 | 2426 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 292 | 0.020 |
Why?
|
| Feedback | 1 | 1995 | 791 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Japan | 1 | 2016 | 1364 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 1991 | 152 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 660 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11065 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3261 | 0.020 |
Why?
|
| Camptothecin | 1 | 1995 | 589 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3533 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4169 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 618 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 3795 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 676 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 1600 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 158 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 1075 | 0.020 |
Why?
|
| Hemeproteins | 1 | 2010 | 61 | 0.020 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 58 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2012 | 449 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1645 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2020 | 8452 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 1415 | 0.020 |
Why?
|
| Light | 1 | 1996 | 1345 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2017 | 1230 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1167 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 625 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3562 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 468 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 101 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1651 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1356 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4258 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 986 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5195 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 377 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2017 | 2205 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2248 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8298 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 607 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3816 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1955 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1844 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 1851 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 2650 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2008 | 70 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 457 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 809 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29493 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1501 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 602 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3680 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2012 | 719 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2008 | 112 | 0.020 |
Why?
|
| Patient Selection | 1 | 2020 | 4235 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2012 | 881 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3095 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2024 | 4651 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 759 | 0.020 |
Why?
|
| Professional Practice | 1 | 2009 | 313 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1995 | 1868 | 0.020 |
Why?
|
| Privacy | 1 | 2009 | 233 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3566 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5411 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2008 | 167 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 2695 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7013 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1865 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 746 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 514 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2058 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2012 | 1147 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 206 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2189 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1218 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 456 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 26173 | 0.020 |
Why?
|
| Body Size | 1 | 2008 | 462 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2007 | 534 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2922 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 603 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2020 | 3416 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2836 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6758 | 0.010 |
Why?
|
| Stem Cells | 1 | 2017 | 3521 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 26950 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18328 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2426 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3432 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 1884 | 0.010 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 609 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1429 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9163 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4918 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2121 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8426 | 0.010 |
Why?
|
| Perception | 1 | 2009 | 1194 | 0.010 |
Why?
|
| Patients | 1 | 2009 | 902 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 3608 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3757 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5736 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4738 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4567 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8551 | 0.010 |
Why?
|
| Medicine | 1 | 2009 | 940 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2012 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5779 | 0.010 |
Why?
|
| Testosterone | 1 | 2011 | 2466 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12260 | 0.010 |
Why?
|
| Data Collection | 1 | 2009 | 3320 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2152 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2202 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3811 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4411 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3388 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23681 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 3984 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9312 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9265 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2185 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1647 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 6128 | 0.000 |
Why?
|